The Real Brokerage (REAX) Earnings Analysis
The Real Brokerage (REAX) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -0.02 USD vs -0.03 USD est (+33.3%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E -64.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does REAX next report earnings?
No confirmed upcoming earnings date is currently scheduled for REAX. This page updates as the calendar is published.
REAX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.02 USD | -0.03 USD | +33.3% | Beat |
| 2026-03-04 | -0.02 USD | -0.03 USD | +33.3% | Beat |
| 2025-10-30 | -0.00204 USD | -0.02 USD | +89.8% | Beat |
| 2025-08-07 | 0.01 USD | 0.0025 USD | +300% | Beat |
| 2025-03-06 | -0.03 USD | -0.05 USD | +40% | Beat |
Beat rate: 5/5 (100%) over reported quarters with consensus data.
REAX valuation and analyst view
| Trailing P/E | -64.16 |
|---|---|
| Trailing EPS | -0.02932 USD |
| Price / book | 6.40 |
| Dividend yield | 0.00% |
| Market cap | 0.41B |
| Analyst consensus | Buy (5 buy / 2 hold / 0 sell) |
| Avg price target | 4.25 USD |
Related research pages
Frequently asked questions
When is The Real Brokerage (REAX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for REAX. This page updates as the calendar is published.
Did REAX beat earnings last quarter?
In its 2026-05-07 report, REAX posted EPS of -0.02 USD versus a -0.03 USD estimate — a beat of 33.3%.
What is REAX's earnings track record?
Over the last 5 reported quarters with consensus data, REAX beat estimates 5 times (100%).
What is REAX's current P/E ratio and EPS?
REAX trades at a trailing P/E of -64.16 on trailing EPS of -0.02932209148456779 USD.
What do analysts rate REAX?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 4.25 USD.